Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, MyeloidBenzamidesFusion Proteins, bcr-ablPiperazinesPyrimidinesLeukemia, Myeloid, AcuteLeukemia, Myeloid, Chronic-PhaseLeukemiaBlast CrisisGenes, ablGene Expression Regulation, LeukemicAntineoplastic AgentsLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeProtein Kinase InhibitorsPhiladelphia ChromosomeCytogenetic AnalysisLeukemia, Myeloid, Accelerated PhaseK562 CellsDrug Resistance, NeoplasmThiazolesRemission InductionLeukemia, Lymphocytic, Chronic, B-CellCytarabineTreatment OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, LymphoidAcute DiseaseBone MarrowLeukemia, ExperimentalNeoplastic Stem CellsHL-60 CellsTransplantation, HomologousKaryotypingBone Marrow TransplantationCytogeneticsRecurrencefms-Like Tyrosine Kinase 3Myelodysplastic SyndromesProtein-Tyrosine KinasesInterferon-alphaHematopoietic Stem CellsNeoplasm, ResidualPrognosisProto-Oncogene Proteins c-bcrHematopoietic Stem Cell TransplantationChromosome AberrationsTranslocation, GeneticAntigens, CD34Disease-Free SurvivalLeukemia, Monocytic, AcuteMutationAntineoplastic Combined Chemotherapy ProtocolsTumor Cells, CulturedSurvival AnalysisDaunorubicinLeukemia Virus, MurineMyeloproliferative DisordersHarringtoninesIn Situ Hybridization, FluorescenceChromosomes, Human, Pair 9Anemia, Refractory, with Excess of BlastsTime FactorsApoptosisNeoplasm ProteinsAnemia, RefractoryGraft vs Host DiseaseSurvival RateRNA, NeoplasmReverse Transcriptase Polymerase Chain ReactionChromosomes, Human, 21-22 and YCell Line, TumorMyeloid-Lymphoid Leukemia ProteinLeukemia, Myelomonocytic, AcuteCore Binding Factor Alpha 2 SubunitChromosomes, Human, Pair 22IdarubicinSalvage TherapyBusulfanDrug ResistanceRNA, MessengerOncogene Proteins, FusionLeukemia, T-CellBone Marrow CellsPolymerase Chain ReactionFlow CytometryImmunophenotypingBase SequenceGranulocytesCell DifferentiationMolecular Sequence DataRetrospective StudiesLeukemia, Radiation-InducedHydroxyureaFollow-Up StudiesDrug Administration ScheduleChromosomes, Human, Pair 21Dose-Response Relationship, DrugLeukocyte TransfusionSarcoma, Myeloid